Cardiotoxicity associated with sunitinib - Authors' reply

The Lancet

Volumn 371, Issue 9620, 2008, Pages 1245-

  Chen, Ming Hui ^a,b   Rupnick, Maria A ^a,b   Chu, Tammy F ^a,b   Force, Thomas ^d   Demetri, George D ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUNITINIB; TROPONIN I;

ACUTE CORONARY SYNDROME; CARDIOTOXICITY; CLINICAL TRIAL; DRUG INDUSTRY; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; LABORATORY TEST; LETTER; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

EID: 41749094301     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60553-X     Document Type: Letter

References (4)

1. Joint European Society of Cardiology/American College of Cardiology. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21 (2000) 1502-1513
2. Alpert J., Thygesen K., Antman E., and Bassand J. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
3. Antman E., Tanasijevic M., Thompson B., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335 (1996) 1342-1349
4. Cardinale D., Sandri M., Martinoni A., et al. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 36 (2000) 517-522